Suppr超能文献

相似文献

1
deficiency exacerbates podocyte injury and autophagy disorder by targeting in diabetic nephropathy.
Autophagy. 2024 May;20(5):1072-1097. doi: 10.1080/15548627.2023.2286128. Epub 2023 Dec 5.
3
Circ_0000285 promotes podocyte injury through sponging miR-654-3p and activating MAPK6 in diabetic nephropathy.
Gene. 2020 Jul 15;747:144661. doi: 10.1016/j.gene.2020.144661. Epub 2020 Apr 7.
4
METTL3 promotes podocyte pyroptosis in diabetic nephropathy through N-methyladenosine modification of TRIM29 mRNA.
Ren Fail. 2025 Dec;47(1):2497492. doi: 10.1080/0886022X.2025.2497492. Epub 2025 May 5.
5
METTL3-mediated mA modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy.
Mol Ther. 2022 Apr 6;30(4):1721-1740. doi: 10.1016/j.ymthe.2022.01.002. Epub 2022 Jan 4.
6
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
Autophagy. 2023 Feb;19(2):505-524. doi: 10.1080/15548627.2022.2080382. Epub 2022 Jun 6.
7
Isoferulic acid regulates CXCL12/CXCR4-mediated apoptosis and autophagy in podocyte and mice with STZ-induced diabetic nephropathy.
Int Immunopharmacol. 2025 Jan 10;144:113707. doi: 10.1016/j.intimp.2024.113707. Epub 2024 Nov 30.

引用本文的文献

1
Research progress on non-coding RNA regulatory networks and targeted therapy in diabetic nephropathy.
Front Endocrinol (Lausanne). 2025 Jul 29;16:1625307. doi: 10.3389/fendo.2025.1625307. eCollection 2025.
2
NSD1-916aa encoded by CircNSD1 contributes to AKI-to-CKD transition through inducing ferroptosis in tubular epithelial cells.
JCI Insight. 2025 Jul 15;10(16). doi: 10.1172/jci.insight.189130. eCollection 2025 Aug 22.
3
Decoding mA RNA methylation in kidney disorders: from molecular insights to therapeutic strategies.
J Transl Med. 2025 Jul 10;23(1):771. doi: 10.1186/s12967-025-06817-4.
4
The role of circ_0050908 in acute myocardial infarction (AMI) and its predictive value for AMI.
J Cardiothorac Surg. 2025 May 29;20(1):247. doi: 10.1186/s13019-025-03478-8.
6
Circ-0069561 as a novel diagnostic biomarker for progression of diabetic kidney disease.
Ren Fail. 2025 Dec;47(1):2490200. doi: 10.1080/0886022X.2025.2490200. Epub 2025 Apr 22.
7
The Role of MA Modification in Autoimmunity: Emerging Mechanisms and Therapeutic Implications.
Clin Rev Allergy Immunol. 2025 Mar 14;68(1):29. doi: 10.1007/s12016-025-09041-6.
9
circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway.
Cell Mol Life Sci. 2025 Feb 19;82(1):79. doi: 10.1007/s00018-025-05613-z.

本文引用的文献

1
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
Autophagy. 2023 Feb;19(2):505-524. doi: 10.1080/15548627.2022.2080382. Epub 2022 Jun 6.
2
METTL3-mediated mA modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy.
Mol Ther. 2022 Apr 6;30(4):1721-1740. doi: 10.1016/j.ymthe.2022.01.002. Epub 2022 Jan 4.
5
MiR-665 Regulates Vascular Smooth Muscle Cell Senescence by Interacting With LncRNA GAS5/SDC1.
Front Cell Dev Biol. 2021 Jul 27;9:700006. doi: 10.3389/fcell.2021.700006. eCollection 2021.
6
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Acta Pharmacol Sin. 2022 Jan;43(1):96-110. doi: 10.1038/s41401-021-00721-5. Epub 2021 Jul 12.
7
miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.
Cell Cycle. 2021 Jul;20(13):1242-1252. doi: 10.1080/15384101.2021.1929677. Epub 2021 Jul 1.
9
MiR-665 inhibits inflammatory response in microglia following spinal cord injury by targeting TREM2.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):65-70. doi: 10.26355/eurrev_202101_24349.
10
Inhibition of miR-665-3p Enhances Autophagy and Alleviates Inflammation in Fusarium solani-Induced Keratitis.
Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):24. doi: 10.1167/iovs.62.1.24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验